Description
This product is intended for practitioner compounding only and is required to be dispensed by a qualified health professional.
(PEA) is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-acyolethanolamines family of lipid mediators .
Features
- PEA is an endogenous fatty acid amide analogue of the endocannabinoid anandamine, from the N-axylethanolamines famiyl of lipid mediators
- PEA Liquid is micronised to a 20um-25um particle size using laser diffraction
- Presented in a coconut-derived (MCT) lipid suspension for ease of compounding
- 2mL contains 300mg PEA for easy dose calculation
- Synthesised from palmitic acid from sustainably sourced palm oil, RSPO certified palm oil
- PEA Liquid contains 99% pure PEA, which has been confirmed by purity testing
- Low allergen, clean formula. Pleasant natural orange flavour.
Ingredients
Each 2 mL contains:
Palmidrol (Palmitoylethanolamide) 300mg
In a base of medium chain triglycerides (fractionated coconut oil), ethanol and cold pressed orange oil.
Dosage
For extemporaneous compounding by a qualified health professional.
Information for compounding: 2mL provides 300mg of palmitoylethanolamide
Cautions
- Compounding preparations should be supplied to an individual only after consultation with a health professional
- It is required that a label is attached to the medicine providing instructions for use for the individuals
- Contains ethanol 6% v/v as a preservative
- KEEP OUT OF REACH OF CHILDREN
- Do not use if seal on cap is broken.
- Shake well before use